Decrease and loss of vascular  -adrenergic response in hindlimbs of dogs with chronic aortic coarctation.
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000804:Angiotensin II / Q000494:pharmacology; D000818:Animals; D001017:Aortic Coarctation / Q000503:physiopathology*; D001366:Axillary Artery / Q000503:physiopathology; D002339:Carotid Arteries / Q000503:physiopathology; D004285:Dogs; D004837:Epinephrine / Q000494:pharmacology; D005263:Femoral Artery / Q000187:drug effects; D006614:Hindlimb / Q000098:blood supply*; D007545:Isoproterenol / Q000494:pharmacology; D009638:Norepinephrine / Q000494:pharmacology; D010477:Perfusion; D011941:Receptors, Adrenergic; D011955:Receptors, Drug; D013566:Sympathomimetics / Q000494:pharmacology; D013997:Time Factors; D014439:Tyramine / Q000494:pharmacology; D014666:Vasomotor System / Q000187:drug effects / Q000503:physiopathology*; D014690:Venous Pressure / Q000187:drug effects
D000319:Adrenergic beta-Antagonists; D011941:Receptors, Adrenergic; D011955:Receptors, Drug; D013566:Sympathomimetics; D000804:Angiotensin II; D007545:Isoproterenol; D009638:Norepinephrine; D014439:Tyramine; D004837:Epinephrine